Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 152

    1.

    Prognostic ability of a panel of immunohistochemistry markers - retailoring of an 'old solution'.

    Brennan DJ, Gallagher WM.

    Breast Cancer Res. 2008;10(1):102. Epub 2008 Feb 25.

    PMID:
    18331621
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.

    Ross JS.

    Adv Anat Pathol. 2009 Jul;16(4):204-15. Review.

    PMID:
    19546609
    [PubMed - indexed for MEDLINE]
    3.

    Current issues in ER and HER2 testing by IHC in breast cancer.

    Gown AM.

    Mod Pathol. 2008 May;21 Suppl 2:S8-S15. Review.

    PMID:
    18437174
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    [Quality assured HER2 analysis in breast cancer. Important therapeutic predictive and prognostic factor].

    Fernö M, Haglund M, Bendahl PO, Olsson H, Rydén L.

    Lakartidningen. 2008 Aug 6-19;105(32-33):2181-4. Swedish. No abstract available.

    PMID:
    18780693
    [PubMed - indexed for MEDLINE]
    5.

    [Integration of new and future biomarkers in the treatment of breast cancer].

    Würtz SØ, Henriksen KL, Lykkesfeldt A, Celis J, Brünner NA.

    Ugeskr Laeger. 2007 Sep 3;169(36):2999-3003. Danish.

    PMID:
    17953881
    [PubMed - indexed for MEDLINE]
    6.

    Predictive molecular markers in the adjuvant therapy of breast cancer: state of the art in the year 2002.

    Di Leo A, Cardoso F, Durbecq V, Giuliani R, Mano M, Atalay G, Larsimont D, Sotiriou C, Biganzoli L, Piccart MJ.

    Int J Clin Oncol. 2002 Aug;7(4):245-53. Review.

    PMID:
    12202978
    [PubMed - indexed for MEDLINE]
    7.

    Immunohistochemical markers as predictive tools for breast cancer.

    Walker RA.

    J Clin Pathol. 2008 Jun;61(6):689-96. Epub 2007 Nov 23. Review.

    PMID:
    18037665
    [PubMed - indexed for MEDLINE]
    8.

    Commercialized multigene predictors of clinical outcome for breast cancer.

    Ross JS, Hatzis C, Symmans WF, Pusztai L, Hortobágyi GN.

    Oncologist. 2008 May;13(5):477-93. Review. Erratum in: Oncologist. 2008 Aug;13(8). doi: 10.1634/theoncologist.2007-0248.

    PMID:
    18515733
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Current status of prognostic profiling in breast cancer.

    Pusztai L.

    Oncologist. 2008 Apr;13(4):350-60. Review.

    PMID:
    18448548
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Breast cancer: the search for new prognostic markers.

    Davis AR.

    Br J Biomed Sci. 1996 Jun;53(2):157-61. Review.

    PMID:
    8757694
    [PubMed - indexed for MEDLINE]
    11.

    Tumor markers. An update approach for their prognostic significance. Part I.

    Agnantis NJ, Goussia AC, Stefanou D.

    In Vivo. 2003 Nov-Dec;17(6):609-18. Review.

    PMID:
    14758728
    [PubMed - indexed for MEDLINE]
    12.

    Quality assurance of predictive markers in breast cancer.

    Rhodes A, Barnes DM.

    Methods Mol Med. 2004;97:29-57. Review. No abstract available.

    PMID:
    15064483
    [PubMed - indexed for MEDLINE]
    13.

    NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry.

    Allred DC, Carlson RW, Berry DA, Burstein HJ, Edge SB, Goldstein LJ, Gown A, Hammond ME, Iglehart JD, Moench S, Pierce LJ, Ravdin P, Schnitt SJ, Wolff AC.

    J Natl Compr Canc Netw. 2009 Sep;7 Suppl 6:S1-S21; quiz S22-3. Review.

    PMID:
    19755043
    [PubMed - indexed for MEDLINE]
    14.

    Hidden HER-2/neu-positive breast cancer: how to maximize detection.

    Carney WP.

    IDrugs. 2009 Apr;12(4):238-42. Review.

    PMID:
    19350468
    [PubMed - indexed for MEDLINE]
    15.

    Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.

    Karlsson E, Delle U, Danielsson A, Olsson B, Abel F, Karlsson P, Helou K.

    BMC Cancer. 2008 Sep 8;8:254.

    PMID:
    18778486
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    TIMP-1 as a tumor marker in breast cancer--an update.

    Würtz SO, Schrohl AS, Mouridsen H, Brünner N.

    Acta Oncol. 2008;47(4):580-90. Review.

    PMID:
    18465326
    [PubMed - indexed for MEDLINE]
    17.

    Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.

    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.

    Breast Cancer Res Treat. 2009 Jul;116(1):131-43. Epub 2008 Jul 31.

    PMID:
    18668363
    [PubMed - indexed for MEDLINE]
    18.

    Factors predictive of response to hormone therapy in breast cancer.

    Rastelli F, Crispino S.

    Tumori. 2008 May-Jun;94(3):370-83. Review.

    PMID:
    18705406
    [PubMed - indexed for MEDLINE]
    19.

    [Predictive and prognostic factors in breast cancer evaluated by immunohistological methods].

    Sinn HP, Magener A, Dürr F, Harcos A, von Minckwitz G.

    Verh Dtsch Ges Pathol. 2001;85:200-5. German. No abstract available.

    PMID:
    11894398
    [PubMed - indexed for MEDLINE]
    20.

    Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.

    Ueda S, Tsuda H, Asakawa H, Shigekawa T, Fukatsu K, Kondo N, Yamamoto M, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H.

    Jpn J Clin Oncol. 2008 Apr;38(4):250-8.

    PMID:
    18407934
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk